TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a license agreement […]
TOKYO, Mar 31, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside […]
TOKYO, Mar 30, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has confirmed it has accepted for review applications for […]
TOKYO, Mar 26, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. has announced that drug discovery research conducted on perampanel (brand name: FYCOMPA, “perampanel”), the AMPA-type glutamate receptor […]
SHANGHAI, CHINA, Mar 19, 2021 – (ACN Newswire via SEAPRWire.com) – Hua Medicine (the “Company”, Stock Code: 2552.HK), today announces the audited annual results of the Company and its subsidiaries […]
TOKYO, Mar 12, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally […]
SINGAPORE – The National Kidney Foundation’s oldest dialysis centre in the west of Singapore has got a new look, thanks to a $2m donation from local charity, the Lew Foundation. […]
SINGAPORE – When the pandemic struck last year, Dr Ho Lai Peng encountered an anxious Covid-19 patient hospitalised at the National Centre for Infectious Diseases (NCID) who was separated from […]
TOKYO, Feb 22, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that it has received orphan drug designation for a prospective indication for unresectable biliary tract cancer with […]
TOKYO, Feb 15, 2021 – (JCN Newswire) – Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced […]
TOKYO, Feb 1, 2021 – (JCN Newswire) – Eisai Co., Ltd. announced today that Eisai Korea Inc., Eisai’s subsidiary in South Korea, has launched the Parkinson’s disease treatment Equfina (safinamide […]
SHANGHAI, CHINA, Dec 18, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment […]
TOKYO, Nov 30, 2020 – (JCN Newswire) – Eisai Co., Ltd. announced today that the company will present the latest data on its in-house discovered and developed anti-epileptic agent (AED) […]
SINGAPORE – Health-tech start-up SenzeHub develops wearables that monitor patients’ vital signs such as heart rate and temperature. These devices help flag any deterioration in the user’s condition and provide […]
TOKYO, Nov 16, 2020 – (JCN Newswire) – Eisai Co., Ltd. announced that it has been received approval from the European Commission for the use of its in-house discovered and […]
SINGAPORE – Patients who are newly diagnosed with human immunodeficiency virus (HIV) will no longer have to wait up to eight weeks before starting treatment. Instead, waiting time for treatment […]
The Covid-19 pandemic is unprecedented in terms of its impact on the world. While other pandemics have been more deadly, such as the plague, cholera and the 1918 Spanish flu, […]
The Covid-19 pandemic is unprecedented in terms of its impact on the world. While other pandemics have been more deadly, such as the plague, cholera and the 1918 Spanish flu, […]
SINGAPORE – National Kidney Foundation (NKF) chairman Koh Poh Tiong will step down on Oct 31, after holding the position for eight years. Mr Koh will be succeeded by Mr […]
TOKYO, Oct 16, 2020 – (JCN Newswire) – Eisai Co., Ltd. announced today that the supplementary new drug applications for its in-house discovered and developed anti-epileptic drug (AED) Fycompa (generic […]
